University of Chicago: Early phase 1 study in Kidney Stones, Calcium Oxalate Kidney Stones (5 participants)

University of Chicago: Early phase 1 study in Kidney Stones, Calcium Oxalate Kidney Stones (5 participants). Its enrollment of 5 is below the median of 80 (1st percentile). Dated 6 days ago, it is inside the fresh trigger window. Score 55/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.

Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2

enrollment: 5 · 1th percentile of 8,879 ClinicalTrialStartPulse records · 0.1x the median

Free preview: all 14 published fields of this record are shown below. Locked: 499 related US ClinicalTrialStartPulse records and the 7-column CSV export.

FieldValue
SponsorUniversity of Chicago
Sponsor typeAcademic and hospital
StudyPhosphate & Kidney Stones
NCT IDNCT07903961
PhaseEarly phase 1
Statusnot yet recruiting
ConditionsKidney Stones; Calcium Oxalate Kidney Stones; Hypophosphatemia
Intervention typesdrug
Target enrollment5
Site countriesUnited States
Posted2026-10-29
Planned start2026-10-31
EventNewly registered study
Event date2026-10-29
enrollment percentile1th of 8,879 (median 80, 0.1x median)
Peer records CSV (500 US records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch University of Chicago

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Free first: a 10-record sample of US records

See the real columns before you buy. One confirmation email, nothing else unless you opt in.

Unlock University of Chicago + 500 US peer records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL

  • Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
  • Record date: 2026-10-29
  • Data refreshed: 2026-11-04
  • Refunds on request within 14 days

Search all US records free →

Top ClinicalTrialStartPulse records (US first): Sanofi · Pfizer · National Institute of Arthritis and Musculoskeletal and Skin · Apple Inc. · National Cancer Institute (NCI) · Browse all by state and category →

LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Peer benchmark and outreach value: University of Chicago and 2,512 US peers

  • US ClinicalTrialStartPulse records like this one: 2,512
  • University of Chicago's enrollment: 1st percentile of 8,879 records
  • Timing: High: dated in the last 7 days
  • Estimated pipeline if you contact every US peer: $502,400 (peers × rate × deal size; an estimate from your assumptions, not a forecast)

Search, filter and export more ClinicalTrialStartPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

55 / 100 Score

  • Posted in the last two weeks.
  • Not yet recruiting: vendors still being chosen.

What is the ClinicalTrialStartPulse record for University of Chicago?

University of Chicago registered a Early phase 1 study (NCT07903961) in Kidney Stones targeting 5 participants, posted 2026-10-29.

How does University of Chicago compare to other ClinicalTrialStartPulse records?

Its enrollment of 5 is below the median (1th percentile); smaller records often move faster and face less competition. It is fresh: dated 6 days ago, inside the window where early outreach matters most.

University of Chicago vs. top 3 peers

OrganizationLocationAmountPercentileRecord date
University of ChicagoUS51st2026-10-29
Apreo Health, Inc.US156th2026-10-27
University of Wisconsin, MadisonUS156th2026-10-23
Mclean HospitalUS3019th2026-10-30

Related records

ClinicalTrialStartPulse: Early phase 1 ClinicalTrialStartPulse: United States sites

More US public-record feeds

U.S. DOT Injury/Illness Summary Pulse in US U.S. DOT FRA Regulated Mode Major Security Events Pulse in US U.S. DOT Crossing Inventory Data Pulse in US U.S. DOT Insur - All With History Pulse in US USAC Telecom CAF Locations Obligation and Deployment by Speed Tier Data Pul in US U.S. CDC 2022 Final Assisted Reproductive Technology Summary Pulse in US U.S. DOT Rail Equipment Accident/Incident Data Subset Pulse in US U.S. DOT Monthly Modal Time Series Pulse in US

How to monitor University of Chicago and peer early phase 1 records

Get new ClinicalTrialStartPulse records like University of Chicago by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get new studies in your therapeutic areas

ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.

Often used together